MENS: Jyong Biotech Ltd Company Short-Term Debt

Symbol and logo of brand Jyong Biotech (MENS)

Jyong Biotech Ltd (MENS) develops safe botanical remedies for urology while minimizing side effects. The short-term borrowing level reflects current liability dynamics, where the metric value stands at 0.00. Asset stability depends on FDA approval and cost control. The company is currently focusing on organic growth and seeking global distribution partners for its medications.

MENS (Jyong Biotech Limited) Company Short-Term Debts history from 06/18/2025 to 10/31/2026

Analytical breakdowns and data insights for company Jyong Bio (MENS)

- current quotes and average value forecast:
Price Chart Jyong Biotech|MENS - Fair Value Consensus
- market capitalization information:
Market Value Jyong Biotech Ltd|MENS - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Jyong Biotech|MENS - Book Capitalization|Market Cap to Net Assets Ratio jyongbio.com|MENS - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Jyong Biotech Ltd|MENS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Jyong Biotech Ltd|MENS - Company Cumulative Indebtedness|Debts to Book Capitalization Jyong Biotech Ltd|MENS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Jyong Biotech|Quick Liquidity jyongbio.com
- net income and valuation multiples indicators:
MENS - Final Profit
Summary company analytics:Jyong Biotech (MENS)
Mass-produced product of jyongbio.com

To stress-test liquidity, an investor must analyze the dynamics of liabilities with maturities of up to one year, which allows for an assessment of the real debt load without accounting for accounting delays. Amid the expansion of Jyong Biotech Ltd (MENS) in the growing men's preventive medicine market, current loans and borrowings demonstrate effective working capital management and the company's ability to finance business development.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts perrigo.com|Company Current Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Short-Term Debt|MNKD: Company Current Liabilities|amphastar.com - Amount of Current Liabilities|PCRX: Company Short-Term Debts|ARS Pharmaceuticals Inc - Company Short-Term Loans and Borrowings|TBPH (Theravance) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tonix Pharmaceuticals Holding Corp. TNXP|Amount of Current Liabilities SXTC (SXT Pharmaceuticals)|EPRX: Company Current Liabilities|Short-Term Debt BioHarvest Sciences Inc|eXoZymes Inc (EXOZ) - Company Short-Term Debt|Short-Term Debt Oramed Pharmaceuticals Inc. (ORMP)|Company Short-Term Debt Entera Bio Ltd|Company Short-Term Indebtedness HYFT (MindWalk Holdings, Inc.)|Company Short-Term Debts ABVC|Cumberland Corp (CPIX) - Short-Term Indebtedness|Quantum BioPharma Ltd - Company Current Liabilities|Company Short-Term Loans and Borrowings FGEN|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|RANI: Company Short-Term Debt|SNYR: Company Short-Term Debts|RLYB - Short-Term Debt Volume|Company Short-Term Debt Lexaria Bioscience Corp|Short-Term Debt pulmatrix.com PULM|Company Current Liabilities PTHL (Pheton Holdings Ltd)|Amount of Current Liabilities APM|Company Short-Term Debts LYRA (Lyra Therapeutics, Inc)|impactbiomedinc.com (IBO) - Short-Term Debt|TNF Pharma - Company Short-Term Debts|cbdMD, Inc. (YCBD) - Company Current Liabilities|PRFX: Company Short-Term Debts|Altamira Therapeutics Ltd. - Company Short-Term Loans and Borrowings|Company Current Liabilities LIPO|OPTN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|Company Short-Term Debt PROC (procapsgroup.com)|Petros Pharmaceuticals, Inc. - Company Current Liabilities|Amount of Current Liabilities QLI (Qilian International Holding Group)|ACELYRIN, Inc. - Company Short-Term Debts|TFFP (TFF Pharmaceuticals, Inc) - Company Short-Term Indebtedness